Evidence map›Paper›PMID 40899600›Full record

ArticleNeurodegenerative disease management2026

A quantitative investigation of the handwriting kinematics in response to STN-DBS in Parkinson's disease patients.

Halil Onder, Zehra Yavuz, Beyza Nur Cetin, Selcuk Comoglu

Abstract read
In one paragraph

Article in Neurodegenerative disease management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Dissociable Handwriting Domains in Parkinson's Disease?Movement disorders clinical practice · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Halil OnderNeurology Clinic, Etlik City Hospital, Ankara, Turkey.ORCID 0000-0002-1823-2278
Zehra YavuzNeurology Clinic, Etlik City Hospital, Ankara, Turkey.
Beyza Nur CetinNeurology Clinic, Etlik City Hospital, Ankara, Turkey.
Selcuk ComogluNeurology Clinic, Etlik City Hospital, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe aim of this manuscript was to investigate possible handwriting alterations focusing on micrographia in PD patients with STN-DBS in distinct stimulation conditions.

methodsAll consecutive PD patients with STN-DBS therapy who visited our movement disorder center between October 2023 and December 2023 and agreed to participate in the study were enrolled. Extensive clinical assessments including various scales were performed. The MDS-UPDRS-III-stimulation-'off' and 'on' scores were evaluated. The handwriting parameters including letter area, writing time and pressure were measured on a digital graphic tablet using an electronic pen. In addition to these parameters, indices related to micrographia were measured under four stimulation conditions (bilateral, left, right, no stimulation).

resultsOverall, we included 20 patients with a mean age of 56.7 ± 11.4 years (F/M = 7/13). The comparisons of the handwriting parameters did not reveal any significant differences between the distinct stimulation conditions. Writing duration showed strong correlations with the HAM-A score (CC = 0.662,

conclusionNo stimulation-related dynamic changes were observed in handwriting kinematics in patients with STN-DBS. These findings might give perspectives regarding the pathophysiology of micrographia in PD as well as mechanisms underlying the efficacy of STN-DBS.

Indexed as

Deep Brain StimulationHandwritingParkinson DiseaseSubthalamic NucleusAdultAgedBiomechanical PhenomenaFemaleHumansMaleMiddle AgedHandwriting kinematicsmicrographiaParkinson’s diseasepathophysiologySTN-DBS

Identifiers

PMID40899600
PMCPMC12826748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.